Table 3 Effect of the tested drugs on mean blood pressure in alloxan-induced diabetic rats

Normal control group

110 ± 4.01

118.25 ± 8.99

108.75 ± 4.57

111.5 ± 4.20

Diabetic control group

112.5 ± 9.14

121.75 ± 11.35

150.75 ± 5.25*

151.25 ± 5.12*

Diabetic group treated with bromocriptine

115 ± 9.12

102.75 ± 6.8

109 ± 10.23^#

121.75 ± 15.26^#

Diabetic group treated with cabergoline

103.75 ± 7.0

105.5 ± 9.14

123 ± 7.87^#

107.75 ± 107.75^#

Diabetic group treated with sarpogrelate

118.75 ± 10.87

114.75 ± 8.53

137.75 ± 8.53

139 ± 18.56

Diabetic group treated with bromocriptine + sarpogrelate

104.5 ± 7.59

104.75 ± 4.99

106.25 ± 11.08^#

118 ± 13.03^#

Diabetic group treated with cabergoline + sarpogrelate

109.25 ± 11.58

105 ± 9.05

106 ± 18.3^#

104.25 ± 5.5^#